Physician profile
Michael P Rubinstein
NPI 1780620013
$2,780.35
in general payments reported to CMS, 2019-2025
14 companies · $291 in 2025
The $291 reported for 2025 was more than what a typical Hand Surgery provider received nationally (typical 2025 total: $270).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $328 · 2020: $23.14 · 2021: $207 · 2022: $1,640 · 2023: $117 · 2024: $174 · 2025: $291.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $582.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $582.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Empire Medical, INC | $1,510.46 | 2021-2024 | |
| Access Pro Medical, LLC | $265.43 | 2025 | Matriderm |
| Stryker Corporation | $221.11 | 2021-2023 | Blueprint Patient Specific Instrumentation |
| Abbott Laboratories | $202.86 | 2023-2024 | Proclaim, Eterna |
| Endo Pharmaceuticals INC. | $201.53 | 2019 | |
| Anika Therapeutics, INC. | $177.89 | 2022 | |
| Axogen | $41.94 | 2019-2021 | |
| Derma Sciences, INC. | $37.25 | 2019 | |
| Mallinckrodt Enterprises LLC | $27.56 | 2019 | |
| Boston Scientific Corporation | $25.69 | 2025 | Wavewriter Alpha Prime 16 |
| Medtronic USA, INC. | $21.37 | 2020 | |
| Forte Bio-Pharma LLC | $19.94 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $15.15 | 2019 | |
| Integra Lifesciences Corporation | $12.17 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Rubinstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.